Lv1
30 积分 2023-03-18 加入
Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000)
3个月前
已完结
Myelin oligodendrocyte glycoprotein antibody-associated disease in children: Are there MRI predictors of relapse?
5个月前
已完结
Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey
6个月前
已完结
Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and review
9个月前
已完结
Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses
10个月前
已完结
The pharmacological management of myelin oligodendrocyte glycoprotein-immunoglobulin G associated disease (MOGAD): an update of the literature
11个月前
已完结
Treatment of MOG-IgG associated disease in paediatric patients: A systematic review
11个月前
已完结
Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and review
11个月前
已完结
Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypes
11个月前
已完结
MOG Antibody Disease: Nuances in Presentation, Diagnosis, and Management
11个月前
已完结
皖公网安备34019202002308
